Zhejiang Huahai Stock Soars to Day High with 5.89% Surge

Zhejiang Huahai Pharmaceutical Co., Ltd. has experienced a notable increase of 5.89% on March 27, 2026, reaching an intraday high of CNY 15.88. This performance stands in contrast to the China Shanghai Composite, which saw a modest gain of 0.63% on the same day. Over the past week, Zhejiang Huahai has shown a positive trend with a 3.4% increase, while the broader market declined by 1.09%. Despite this day's high, the company has faced challenges in its long-term growth trajectory. Over the past year, it has reported a return of just 1.52%, significantly lagging behind the China Shanghai Composite's 22.49% return. The company's financial metrics indicate a debt-to-equity ratio of 0.70 and a price-to-earnings ratio of 43.00, suggesting a relatively high valuation compared to its earnings. Zhejiang Huahai's operating cash flow has reached its lowest point at CNY 947.81 million, and its return on equity stands at 4.24%. The stock's dividend yield is currently at 1.59%, reflecting its ongoing efforts to provide returns to shareholders amidst a challenging market environment.